Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$128,819
-$33,102 QoQ
Shares Held
13,807
-14.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#349
of 639 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Derivatives in HLN
reported options exposure · as of Dec 31, 2023CallValue
$162,954
CallShares
19,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GTS SECURITIES LLC holds $347,776 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (37.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,047 | $218,957 | |
| 2 | HLN |
Haleon plc
This page
|
13,807 | $128,819 | |
| 3 | 271,769 | $0 |
All Filings in HLN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $128,819 | 13,807 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $161,921 | 16,176 | Shares | Defined | 2026-05-15 | |
| 2025-06-30 | $177,503 | 17,117 | Shares | Defined | 2025-08-08 | |
| 2023-12-31 | $162,954 | 19,800 | Call | Defined | 2024-02-15 | |
| 2023-12-31 | $260,405 | 31,641 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $338,198 | 40,600 | Put | Defined | 2023-11-15 | |
| 2023-09-30 | $535,127 | 64,241 | Shares | Defined | 2023-11-15 | |
| 2023-09-30 | $164,101 | 19,700 | Call | Defined | 2023-11-15 | |
| 2023-06-30 | $537,040 | 64,086 | Shares | Defined | 2023-08-16 | |
| No filing history on record for this holder in this stock. | ||||||